fig2

Impact of genetic variants in the solute carrier (<i>SLC</i>) genes encoding drug uptake transporters on the response to anticancer chemotherapy

Figure 2. Relationship between genetic variants of pharmacologically relevant members of the SLC family 22, substrate drugs affected by changes in these proteins, and cancers treated with these compounds. SLC: Solute carrier; SLCO: family of organic anion transporting polypeptides (OATPs enconded by SLCO genes).

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/